MarketCap
Facebook
X
TelegramQuarterly report 2023-Q1
added 05-12-2023
PolarityTE DIO Ratio 2011-2026 | PTE
Annual DIO Ratio PolarityTE
| 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| - | 37.3 | 72.9 | 37.1 | 86.7 | - | - | - | 16.5 | 50.5 | 31.9 | 53.1 |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 86.7 | 16.5 | 48.2 |
Quarterly DIO Ratio PolarityTE
| 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| - | - | - | - | - | - | 5.47 | 22.2 | 26.5 | - | 59.6 | 91.3 | 100 | - | 35.6 | 38.6 | 34.6 | 80.5 | 46 | 185 | 15.3 K | - | - | - | - | - | - | - | 98.9 | 5.85 | - | 4.23 | 378 | 10.6 | 5.02 | 66.6 | 66 | 22.8 | 17.2 | 160 | 89.1 | 16.9 | 10.6 | 126 | 19.4 | 18.4 | 18 | 91.3 | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 15.3 K | 4.23 | 540 |
DIO Ratio of other stocks in the Biotechnology industry
| Issuer | DIO Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
|
239 | $ 9.21 | - | $ 596 M |  USA |
 |
Midatech Pharma plc
MTP
|
40.6 | - | -18.52 % | $ 27.3 M |  Britain |
 |
Alexion Pharmaceuticals, Inc.
ALXN
|
512 | - | - | $ 40.3 B | USA |
 |
Aptorum Group Limited
APM
|
4.89 | $ 0.87 | -2.13 % | $ 6.4 M |  China |
 |
ACADIA Pharmaceuticals
ACAD
|
295 | $ 22.43 | 1.04 % | $ 3.72 B | USA |
 |
Институт стволовых клеток человека
ISKJ
|
275 | - | - | - |  Russia |
 |
Aeterna Zentaris
AEZS
|
55.6 | - | 5.93 % | $ 314 M |  Canada |
 |
Aquestive Therapeutics
AQST
|
120 | $ 4.08 | 0.83 % | $ 436 M | USA |
 |
Arcutis Biotherapeutics
ARQT
|
185 | $ 22.93 | 2.48 % | $ 2.92 B | USA |
 |
Edesa Biotech
EDSA
|
184 | $ 15.77 | -0.82 % | $ 50.4 M | USA |
 |
Autolus Therapeutics plc
AUTL
|
70.7 | $ 1.43 | 1.06 % | $ 381 M | Britain |
 |
AstraZeneca PLC
AZN
|
206 | - | - | $ 96.9 B | Britain |
 |
BioDelivery Sciences International
BDSI
|
321 | - | -4.8 % | $ 255 M | USA |
 |
Exelixis
EXEL
|
96.1 | $ 45.02 | 0.73 % | $ 12.2 B | USA |
 |
BeiGene, Ltd.
BGNE
|
304 | - | 0.49 % | $ 251 B |  Cayman-islands |